Immunopathogenic mechanisms in schistosomiasis: What can be learnt from human studies?

Trends in Parasitology

Volumn 22, Issue 2, 2006, Pages 85-91

  Abath, Frederico G C ^a   Morais, Clarice N L ^a   Montenegro, Carlos Eduardo L ^b   Wynn, Thomas A ^c   Montenegro, Silvia M L ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; GRANULOMA; HEPATOSPLENIC DISEASE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LIVER FIBROSIS; NONHUMAN; PORTAL HYPERTENSION; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PARASITE RELATIONS; HUMANS; INTERLEUKIN-10; LIVER CIRRHOSIS; LIVER DISEASES; MICE; SCHISTOSOMIASIS; SPLENIC DISEASES;

SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 31344468508     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.12.004     Document Type: Review

References (60)

1. R.M. Zinkernagel, and H. Hengartner Regulations of the immune response by antigen Science 293 2001 251 253
2. S.M. Phillips Mechanisms of immunopathology in parasitic infections K.S. Warren Immunology and molecular biology of parasite infections 3rd edn 1993 Blackwell Scientific Publications
3. M.J. Stadecker The immunobiology of Th1 polarization in high-pathology schistosomiasis Immunol. Rev. 201 2004 168 179
4. E.J. Pearce, and A.S. MacDonald The immunobiology of schistosomiasis Nat. Rev. Immunol. 2 2002 499 511
5. A.W. Cheever Immunopathology of schistosomiasis mansoni in mice and men Immunol. Today 21 2000 465 466
6. A.W. Cheever Experimental models of Schistosoma mansoni infection Mem. Inst. Oswaldo Cruz 97 2002 917 940
7. D.W. Dunne, and E.J. Pearce Immunology of hepatosplenic schistosomiasis mansoni: a human perspective Microbes Infect. 1 1999 553 560
8. P.G. Fallon Immunopathology of schistosomiasis: a cautionary tale of mice and men Immunol. Today 21 2000 29 34
9. A.B. Stavitsky Regulation of granulomatous inflammation in experimental models of schistosomiasis Infect. Immun. 72 2004 1 12
10. T.A. Wynn Immunopathogenesis of schistosomiasis Immunol. Rev. 201 2004 156 167
11. K.F. Hoffmann Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology Adv. Parasitol. 52 2002 265 307
12. A. Dessein Interleukin-13 in the skin and interferon-γ in the liver are key players in immune protection in human schistosomiasis Immunol. Rev. 201 2004 180 190
13. L.C. Malaquias Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses Scand. J. Immunol. 46 1997 393 398
14. M.E. Williams Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens J. Infect. Dis. 170 1994 946 954
15. S.M. Montenegro Cytokine production in acute versus chronic human schistosomiasis mansoni: the cross-regulatory role of interferon-gamma and interleukin- 10 in the responses of peripheral blood mononuclear cells and splenocytes to parasite antigens J. Infect. Dis. 179 1999 1502 1514
16. A.R. de Jesus Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni J. Infect. Dis. 185 2002 98 105
17. J.L. Grogan Antigen-specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection J. Infect. Dis. 177 1998 1433 1437
18. I.R.C. Viana Interferon-γ production by pripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni Trans. R. Soc. Trop. Med. Hyg. 88 1994 466 470
19. A.M. Silveira Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures Trans. R. Soc. Trop. Med. Hyg. 98 2004 514 519
20. M.I. Araujo The absence of gamma-interferon production of S. mansoni antigens in patients with schistosomiasis Braz. J. Med. Biol. Res. 27 1994 1619 1625
21. M.I. Araujo Evidence of a T helper type 2 activation in human schistosomiasis Eur. J. Immunol. 26 1996 1399 1403
22. J.K. Mwatha High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni J. Immunol. 160 1998 1992 1999
23. C. Contigli Phenotype and cytokine profile of Schistosoma mansoni specific T cell lines and clones derived from schistosomiasis patients with distinct clinical forms Clin. Immunol. 91 1999 338 344
24. A.R. de Jesus Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection Infect. Immun. 72 2004 3391 3397
25. C.L. King Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity J. Immunol. 156 1996 4715 4721
26. T.A. Wynn IL-10 regulates liver pathology in acute murine schistosomiasis mansoni but is not required for immune down-modulation of chronic disease J. Immunol. 160 1998 4473 4480
27. F.K. Hoffmann Il-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis J. Immunol. 164 2000 6406 6416
28. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development J. Immunol. 173 2004 1224 1231
29. M. Hesse The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells J. Immunol. 172 2004 3157 3166
30. P.O. Flores-Villanueva Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensivity reactions and egg granuloma formation in schistosomiasis J. Immunol. 156 1996 3315 3320
31. T.A. Wynn Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1-and T helper cell 2-type cytokine responses in vivo J. Immunol. 159 1997 5014 5023
32. S.M. Montenegro Enhanced interleukin-12 and CD40 ligand activities but reduced Staphylococcus aureus Cowan 1-induced responses suggest a generalized and progressively impaired type 1 cytokine pattern for human schistosomiasis Infect. Immun. 70 2002 5903 5912
33. +T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling J. Exp. Med. 187 1998 619 629
34. M.A. Montesano Expression of cross-reactive, shared idiotypes on anti-SEA antibodies from humans and mice with schistosomiasis J. Immunol. 145 1990 1002 1008
35. +T cell responses during infection with the helminth Schistosoma mansoni J. Immunol. 157 1996 3046 3053
36. M.G. Chiaramonte Regulation and function of the interleukin 13 receptor ×2 during a T helper cell typer 2-dominant immune response J. Exp. Med. 197 2003 687 701
37. M.M. Mentink-Kane IL-13 receptor α 2 down-modulate granulomatous inflammation and prolongs host survival in schistosomiasis Proc. Natl. Acad. Sci. U. S. A. 101 2004 586 590
38. M.A. Montesano Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease J. Exp. Med. 195 2002 1223 1228
39. M.G. Chiaramonte Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis Hepatology 34 2001 273 282
40. M. Booth Periportal fibrosis in human schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender J. Immunol. 172 2004 1295 1303
41. S. Henri Cytokine Regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease J. Immunol. 169 2002 929 936
42. Z.A. Andrade Schistosomal hepatopathy Mem. Inst. Oswaldo Cruz 99 2004 51 57
43. B.J. Vennervald Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis Trop. Med. Int. Health 9 2004 461 470
44. B.J. Vennervald, and D.W. Dunne Morbidity in schistosomiasis: an update Curr. Opin. Infect. Dis. 17 2004 439 447
45. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol. Today 17 1996 138 146
46. + Regulatory T cells suppress differentiation and functions of Th1 and Th2 Cells, leishmania major infection, and colitis in mice J. Immunol. 170 2003 394 399
47. L.L. Carter, and R.W. Dutton Type 1 and type 2: a fundamental dichotomy for all T-cell subsets Curr. Opin. Immunol. 8 1996 336 342
48. E.J. Pearce Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni J. Exp. Med. 173 1991 159 166
49. M.J. Stadecker The development of granulomas in schistosomiasis: genetic backgrounds, regulatory pathways, and specific egg antigen responses that influence the magnitude of disease Microbes Infect. 1 1999 505 510
50. M. Hesse NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, Il-12, in a Th2 model of granulomatous disease Am. J. Pathol. 157 2000 945 955
51. E.A. Patton Severe Schistosomiasis in the absence of Interleukin-4 (IL-4) is IL-12 independent Infect. Immun. 69 2001 589 592
52. D.E. Gomez Expression of metalloproteinases (MMP-1 and MMP-2) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis Am. J. Trop. Med. Hyg. 61 1999 9 13
53. Z.A. Andrade Myofibroblasts in schistosomal portal fibrosis of man Mem. Inst. Oswaldo Cruz 94 1999 87 93
54. J.C. Bina, and A. Prata Esquistossomose na área hiperendêmica de Taquarandi. Infecção pelo Schistosoma mansoni e formas graves Rev. Soc. Bras. Med. Trop. 36 2003 211 216
55. T.K. Arap Siongok Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya Am. J. Trop. Med. Hyg. 25 1976 273 284
56. R.J. Quinnell Genetics of susceptibility to human helminth infection Int. J. Parasitol. 33 2003 1219 1231
57. A.J. Dessein Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene Am. J. Hum. Genet. 65 1999 709 721
58. S. Marquet Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33 Nat. Genet. 14 1996 181 184
59. V. Rodrigues Genetic control of Schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes Infect. Immun. 67 1999 4689 4692
60. W.E. Secor Association of hepatosplenic schistosomiasis with HLA-DQB1*0201 J. Infect. Dis. 174 1996 1131 1135